Armillary spheres, planetaria, astronomic orbits, atomic models, molecular modelsSphères armillaires, planétariums, orbites astronomiques, schémas d'atomes, schémas de molécules

1 . 13 . 15

Atomic models, molecular models, representations of human, animal or vegetal cells, images of bacteria or viruses, DNA helixesSchémas atomiques, schémas de molécules, représentations de cellules humaines, animales ou végétales, images de bactéries ou de virus, hélices d'ADN

26 . 11 . 1

One line or one bandUne ligne ou une bande

26 . 11 . 3

More than two lines or two bandsPlus de deux lignes ou de deux bandes

26 . 11 . 7

Vertical lines or bandsLignes ou bandes verticales

26 . 11 . 10

Straight lines or bandsLignes ou bandes droites

26 . 11 . 12

Curved lines or bands (except a 26.11.13)Lignes ou bandes courbes (excepté a 26.11.13)

26 . 2 . 1

Segments of circles or ellipses (except 26.2.7)Segments de cercle ou d'ellipse (excepté 26.2.7)

26 . 2 . 5

Joined or intersecting segments or sectors of circles or ellipsesSegments ou secteurs de cercle ou d'ellipse, accolés ou se coupant

26 . 2 . 24

Segments or sectors of circles or ellipses, semi-circles or semi-ellipses with dark surfaces or parts of surfacesSegments ou secteurs de cercles ou ellipses, demi-cercles ou demi-ellipses avec surface ou partie de la surface foncée

26 . 1 . 26

Circles or ellipses with cutout areasCercles ou ellipses avec des zones découpées

Trademark usage description

pharmaceutical preparations containing nucleic acid sequences that encode monoclonal antibodies for the treatment of cancer, autoimmune diseases, rare Read More

Classification Information

Class [005]
Pharmaceutical preparations containing nucleic acid sequences that encode monoclonal antibodies for the treatment of cancer, autoimmune diseases, rare diseases, infectious diseases, inflammatory diseases, and blood disorders; pharmaceutical compositions for the prevention and treatment of cancer, autoimmune diseases, rare diseases, infectious diseases, inflammatory diseases, and blood disorders; nucleic acid sequences for medical purposes; pharmaceutical compositions, namely, a nucleotide sequence that encodes an antigen, such as a DNA plasmid having an antigen encoding sequence and like DNA, for the prevention and treatment of cancer, autoimmune diseases, rare diseases, infectious diseases, inflammatory diseases, and blood disorders; pharmaceutical preparations for human use for the treatment and prevention of cancer, autoimmune diseases, rare diseases, infectious diseases, inflammatory diseases, and blood disorders; pharmaceutical preparations for human and veterinary use, namely, antibiotics, antifungals and anti-virals; gene therapy and prophylactic products, namely, gene delivery pharmaceuticals for the treatment of genetic or cell based conditions.

Classification kind code

Class [010]
Medical apparatus for the administration of biopharmaceuticals and vaccines, namely, drug delivery devices and systems; medical devices, namely, for electroporation mediated administration of drugs to humans and animals; delivery systems for administration of biopharmaceuticals and vaccines for the preventive or treatment of disease in humans and animals; handheld medical systems and devices using electroporation for the prevention or treatment of cancer, autoimmune diseases, rare diseases, infectious diseases, inflammatory diseases, and blood disorders in humans and animals; handheld clinical delivery systems and devices for the application of electrical fields in tissue, in particular muscle and skin, in conjunction with the administration of biopharmaceuticals.

Classification kind code

Mark Details

Serial Number

2118263

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 48 on 23^rd Jun 2022	Agent Changed
Submitted for opposition 256 on 02^th May 2022	Notification of Possible Opposition Sent
Submitted for opposition 80 on 21^st Apr 2022	Change of Title Registered
Submitted for opposition 135 on 14^th Oct 2021	Amendment to Application
Submitted for opposition 48 on 15^th Sep 2021	Agent Changed
Submitted for opposition 257 on 01^st Jul 2021	Designation Notification - Madrid Protocol
Submitted for opposition 1 on 01^st Jul 2021	Created
Submitted for opposition 31 on 01^st Jul 2021	Formalized
Submitted for opposition 30 on 29^th Apr 2021	Filed
Submitted for opposition 228 on 29^th Apr 2021	International Registration